KBC Group’s Immunomedics Inc IMMU Stock Holding History

KBC Group’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-9,015	Closed	-$28K	–	1318
2015 Q4	$28K	Buy	+9,015	New	+$25.2K	﹤0.01%	1224

Other funds holding IMMU

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

KBC Group's IMMU Position: Q1 2016 in Review

KBC Group sold out of Immunomedics Inc (IMMU) in Q1 2016, closing a stake of 9,015 shares — an estimated $28K sold.

KBC Group first reported a position in IMMU in Q4 2015 and held it in 1 quarter. The position peaked at $28K in Q4 2015. 87 funds tracked by Wall St. Rank hold IMMU as of Q1 2016.

KBC Group reported no remaining Immunomedics Inc position as of Q1 2016 after selling out during the quarter.
KBC Group sold 9,015 Immunomedics Inc shares in Q1 2016, an estimated $28K.
KBC Group first reported a position in Immunomedics Inc in Q4 2015 and held it in 1 quarter.
KBC Group's Immunomedics Inc position peaked at $28K in Q4 2015.
87 funds tracked by Wall St. Rank held Immunomedics Inc as of Q1 2016.

Based on KBC Group's 13F filing for Q1 2016, filed 11 May 2016.